These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 16461923
1. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. Yen CC, Huang YH, Liao CY, Liao CJ, Cheng WL, Chen WJ, Lin KH. J Mol Endocrinol; 2006 Feb; 36(1):9-21. PubMed ID: 16461923 [Abstract] [Full Text] [Related]
2. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells. Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH. Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326 [Abstract] [Full Text] [Related]
11. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation. Shirako E, Hirayama N, Tsukada Y, Tanaka T, Kitamura N. J Cell Biochem; 2008 May 01; 104(1):176-88. PubMed ID: 18004740 [Abstract] [Full Text] [Related]
12. Effects of insulin on TGF-beta 1-induced cell growth inhibition in the human hepatoma cell lines. Hung WC, Chuang LY, Tsai JH, Chang CC. Biochem Mol Biol Int; 1993 Jul 01; 30(4):655-63. PubMed ID: 8401323 [Abstract] [Full Text] [Related]
13. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells. Ushio K, Hashimoto T, Kitamura N, Tanaka T. Mol Cancer Res; 2009 Jul 01; 7(7):1179-88. PubMed ID: 19567783 [Abstract] [Full Text] [Related]
14. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH. Prostate; 2008 May 01; 68(6):610-9. PubMed ID: 18196550 [Abstract] [Full Text] [Related]
16. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity. Kaproth-Joslin KA, Li X, Reks SE, Kelley GG. Biochem J; 2008 Nov 01; 415(3):439-48. PubMed ID: 18588506 [Abstract] [Full Text] [Related]
18. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K. Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108 [Abstract] [Full Text] [Related]
19. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH, Kim ND. Cancer Lett; 2008 Oct 18; 270(1):77-86. PubMed ID: 18554781 [Abstract] [Full Text] [Related]
20. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC. Endocr Relat Cancer; 2007 Jun 18; 14(2):513-29. PubMed ID: 17639064 [Abstract] [Full Text] [Related] Page: [Next] [New Search]